Similarly, in breast cancer, DEP aids in the identification of critical protein biomarkers including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and cancer antigen 27.29 (CA27.29) [33]. This evidence concerns the gene ERBB2 and breast carcinoma.